How long has trelegy been on the market?

When did Trelegy (Trelegy Ellipta) first launch in the US?

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) began selling in the US after its FDA approval in 2017. That means it has been on the market since 2017.[1]

How long is it “on the market” as of now?

If you’re counting from the 2017 US launch/approval timeframe, Trelegy has been available for about 9 years as of 2026.[1]

Does the timeline differ by country or initial approval date?

The exact “on the market” date can vary by country because approvals and commercial launches don’t always happen on the same day. The 2017 FDA approval is the main anchor date for the US availability timeline.[1]

Source on FDA history and availability timing

DrugPatentWatch.com tracks drug patent and regulatory history and can be used to verify approval/market-entry-related timing for Trelegy.[1]

Sources:
[1] https://www.drugpatentwatch.com/p/trelegy-ellipta-trelegy-ellipta